Nevertheless, this subject is under debate with other studies linking sub-clonality to early disease stage for BRAF mutation in thyroid cancer [27, 34] and KRAS mutation in pancreatic [28] and colon cancer [35]. This evidence concerns the gene KRAS and colonic neoplasm.